Gemina Laboratories Ltd. (GLABF)
OTCMKTS · Delayed Price · Currency is USD
0.0500
-0.0191 (-27.64%)
At close: Dec 31, 2025
Gemina Laboratories Market Cap
Gemina Laboratories has a market cap or net worth of $1.69 million as of February 12, 2026. Its market cap has decreased by -94.14% in one year.
Market Cap
1.69M
Enterprise Value
1.87M
Revenue
7.76K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since August 11, 2021, Gemina Laboratories's market cap has decreased from 17.07M to 1.69M, a decrease of -90.10%. That is a compound annual growth rate of -40.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.69M | -49.55% |
| Dec 31, 2025 | 3.35M | -91.83% |
| Dec 27, 2024 | 41.03M | 36.86% |
| Dec 29, 2023 | 29.98M | 26.61% |
| Dec 30, 2022 | 23.68M | 41.55% |
| Dec 29, 2021 | 16.73M | -1.98% |
| Aug 11, 2021 | 17.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioxytran | 5.30M |
| Clearside Biomedical | 5.10M |
| AXIM Biotechnologies | 4.99M |
| Enzon Pharmaceuticals | 4.79M |
| Nymox Pharmaceutical | 4.08M |
| Vaccinex | 3.99M |
| Burzynski Research Institute | 3.94M |
| Enzolytics | 2.90M |